Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-21-014620

CEO acquired 69,375 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Evans John M. CEO 2021-03-31 Grant or award +69,375 1,040,332 D
Derivatives
Evans John M. CEO 2021-03-31 Grant or award · Stock Option (Right to Buy) +138,750 138,750 D
Loading xslF345X03/doc4.xml…